GAA rs386833733: Understanding This Rare Genetic Variant

What each genotype means

What is rs386833733?

The variant rs386833733, also identified in clinical literature as p.Arg854Ter or c.2560C>T, is a specific alteration in the DNA sequence of the GAA gene. In genetics, a nonsense mutation like this one introduces a premature stop signal in the genetic instructions. This effectively tells the cell to stop building the protein before it is complete, often resulting in a truncated, non-functional, or unstable protein product. Because this variant occurs within the coding region of the gene, it is considered a high-impact change. It is cataloged in medical databases as a pathogenic variant, meaning it is known to disrupt the normal function of the gene product. Understanding such variants is a primary focus of clinical genetics, as they provide the molecular basis for diagnosing rare, inherited metabolic conditions.

The Role of the GAA Gene

The GAA gene provides the essential instructions for the body to produce an enzyme called acid alpha-glucosidase, also known as acid maltase. This enzyme is primarily active within lysosomes, which are the recycling centers of the cell. Its main job is to break down complex sugars, specifically glycogen, into simpler glucose molecules that the body can use for energy. When the GAA gene contains pathogenic variants that prevent the production of functional enzyme, glycogen begins to accumulate to toxic levels inside the lysosomes. This buildup primarily affects muscle tissues, including the heart and skeletal muscles, leading to the clinical features observed in Pompe disease. Because the body relies on this enzyme for cellular maintenance, the loss of its activity has significant physiological consequences.

Clinical Associations and Evidence

Research associates the rs386833733 variant with Pompe disease, a rare autosomal recessive lysosomal storage disorder. Because it is recessive, an individual typically needs to inherit two copies of a pathogenic variant—or one copy of this variant paired with another pathogenic variant—to experience the symptoms of the condition. The evidence for this variant's pathogenicity is supported by clinical databases like ClinVar, which classify it as pathogenic based on its predicted effect on the GAA protein. Pompe disease itself is categorized by the age of symptom onset, ranging from severe infantile-onset cases involving cardiomyopathy to late-onset forms characterized by progressive muscle weakness. While the link between this specific mutation and the disease is established, the clinical severity can vary depending on the specific combination of variants an individual carries.

Population Frequency

Genetic variants associated with rare diseases are typically found at very low frequencies in the general population. According to data from the Genome Aggregation Database (gnomAD), the rs386833733 variant is rare, with an allele frequency of approximately 0.002 in African and African-American populations. Because this variant is so uncommon, the likelihood of an individual carrying two copies is extremely low. Population databases are essential for researchers to distinguish between common benign variations and rare, disease-causing mutations. By tracking these frequencies across different ancestral groups, scientists can better understand the distribution of genetic risk factors globally. It is important to note that these frequencies represent the presence of the variant in the population, not the prevalence of the disease itself, which is influenced by complex inheritance patterns.

What This Information Means for You

If you have received information about this variant, it is important to understand that genetic testing results should always be interpreted by a qualified healthcare professional, such as a genetic counselor or a medical geneticist. This variant is associated with a serious condition, and its presence does not automatically mean an individual will develop symptoms, especially if they only carry a single copy. Genetic information is complex, and clinical context—such as family history and physical symptoms—is required to make an accurate assessment. You cannot diagnose yourself or others based on a single SNP result. If you are concerned about your carrier status or potential health risks, consult with your clinician to discuss appropriate testing, follow-up, and what these findings mean for your specific health situation.

Frequently asked questions

Sources & further reading

Related variants in GAA